Dergiler / European Journal of Breast Health / 2019 / Cilt: 15 - Sayı: 4

Determining Breast Cancer Treatment Costs Using the Top Down Cost Approach

Sayfa
242–248
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results obtained from studies on disease costs calculated using the top down cost approach provide data on actual healthservices use and therefore are seen as important tools for healthcare administrators in terms of effctive resource allocation.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Breast cancer is the most common type of cancer among women in Turkey, with approximately 15.000 breast cancer diagnoses each year.In this study, our goal was to determine annual direct medical costs of all breast cancer patients in Turkey with top down cost approach.Materials and Methods: Data regarding patients who have been diagnosed with breast cancer and received health services from any hospital inTurkey in 2014 were used for the purpose of the study.
📊
Temel Bulgular & Veri:Data were obtained from the MEDULA System for a total of 126.664 patient.
💡
Sonuç & Katkı:Results obtained from studies on disease costs calculated using the top down cost approach provide data on actual healthservices use and therefore are seen as important tools for healthcare administrators in terms of effctive resource allocation.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Breast cancer is the most common type of cancer among women in Turkey, with approximately 15.000 breast cancer diagnoses each year.In this study, our goal was to determine annual direct medical costs of all breast cancer patients in Turkey with top down cost approach.Materials and Methods: Data regarding patients who have been diagnosed with breast cancer and received health services from any hospital inTurkey in 2014 were used for the purpose of the study. Data were obtained from the MEDULA System for a total of 126.664 patient. Treatment of costsof patients were calculated based on types of patient admissions (inpatient/outpatient/intensive care) and costs of drugs and medical equipment. Indirectcosts and out of pocket costs were not included.Results: Total medical costs of 126,664 patients was calculated as $116.792.107,9, with an average treatment cost per patient of $922,1. Based on typesof patient admission, intensive care treatment had the highest average cost with $2.916.5. In metastatic breast cancer patients, average annual treatmentcost per patient is $2.326,6, which is 2.8 times higher compared to non-metastatic breast cancer patients.Conclusion: In order to ensure effctive resource allocation at micro and macro level, healthcare administrators have to learn costs of diseases with highincidence such as breast cancer. Results obtained from studies on disease costs calculated using the top down cost approach provide data on actual healthservices use and therefore are seen as important tools for healthcare administrators in terms of effctive resource allocation.

🔖

Bu Makaleye Atıf Yap

TEKİN, R. N., SAYGILI, M. (2022). Determining Breast Cancer Treatment Costs Using the Top Down Cost Approach. European Journal of Breast Health, Cilt: 15 - Sayı: 4, 242–248. https://ajindex.com/articles/510795

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. Globocan. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 2012. Available from: URL: http:// globocan.iarc.fr/Default.aspx
  2. Davies EL. Breast Cancer. Medicine 2016; 44: 42-46. [CrossRef] 3. Allaire BT, Ekwueme DU, Guy GP Jr, Li C, Tangka FK, Trivers KF, Sabatino SA, Rodriguez JL, Trogdon JG. Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years. Am J Prev Med 2016; 50: 270-277. (PMID: 26775906) [CrossRef] 4. Ilter H, Keskinkılıç B. Cancer Statistics of Turkey 2014, Republic of Turkey, Ministry of Health, Directorate General of Public Health, Ankara. 2017. Available from: URL: https://hsgm.saglik.gov.tr/depo/birimler/ kanser-db/istatistik/2014-RAPOR._uzuuun.pdf 5. Tuncer M. National Cancer Program 2009-2015. Republic of Turkey, Ministry of Health, Department of Cancer Control. Ankara. 2009. Available from: URL:
  3. Hassett MJ, Elkin EB. What Does Breast Cancer Treatment Cost and What Is It Worth? Hematol Oncol Clin N Am 2013; 27:829-841. (PMID: 23915747) [CrossRef] 7. Pallis A, Tsiantou V, Simou E, Maniadakis N. Pharmacoeconomic considerations in the treatment of breast cancer. Clinicoecon Outcomes Res 2010; 2: 47-61. (PMID: 21935314) [CrossRef] 8. Barron JJ, Quimbo R, Nikam PT, Amonkar MM. Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Res Treat 2008; 109: 367-377. (PMID: 17674201) [CrossRef] 9. Will BP, Berthelot JM, Le Petit C, Tomiak EM, Verma S, Evans WK. Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer 2000; 36: 724-735. (PMID: 10762744) [CrossRef] 10. Khanna R, Madhavan SS, Bhanegaonkar A, Remick SC. Prevalence, healthcare utilization, and costs of breast cancer in a state Medicaid fee-for-service program. J Womens Health 2011; 20: 739-747. (PMID: 21417935) [CrossRef] 11. Max W, Sung HY, Stark B. Th economic burden of breast cancer in California. Breast Cancer Res Treat 2009; 116: 201-207. (PMID: 18683041) [CrossRef] 12. Blumen H, Fitch K, Polkus V. Comparison of treatment costs for breast cancer, by tumor stage and type of service. Am Health Drug Benefis 2016; 9: 23-32. (PMID: 27066193
  4. Hoang Lan N, Laohasiriwong W, Frederick Stewart J, Dinh Tung N, Coyte PC. Cost of treatment for breast cancer in central Vietnam. Glob Health Action 2013; 6: 18872. (PMID: 23394855) [CrossRef] 14. Hodgson TA, Meiners MR. Cost-of-i